Thierry Van EffelterreSummaryAffiliation: GlaxoSmithKline Biologicals Country: Belgium Publications
 Collaborators

Detail Information
Publications
 Modelbased projections of the populationlevel impact of hepatitis A vaccination in MexicoThierry Van Effelterre
Global Clinical Research and Development GlaxoSmithKline Biologicals, Wavre, Belgium
Hum Vaccin Immunother 8:1099108. 2012..The model indicated that universal infant HAV vaccination could substantially reduce the burden of HAV disease in Mexico...  A mathematical model of hepatitis a transmission in the United States indicates value of universal childhood immunizationThierry P Van Effelterre
GlaxoSmithKline Biologicals, Rixensart, B 1330, Belgium
Clin Infect Dis 43:15864. 2006..Mathematical models of HA transmission, especially those accounting for herd protection, can be useful in formulating new, highly effective recommendations that could lead to disease elimination...  A mathematical model of the indirect effects of rotavirus vaccinationT Van Effelterre
GlaxoSmithKline Biologicals, Wavre 1300, Belgium
Epidemiol Infect 138:88497. 2010....  A dynamic model of pneumococcal infection in the United States: implications for prevention through vaccinationThierry Van Effelterre
GSK Biologicals, Wavre, Belgium
Vaccine 28:365060. 2010..In addition, serotype changes following vaccine introduction may have multifactorial origins, with antibiotic use an important factor for resistant strains such as 19A...  The role of simple mathematical models in malaria elimination strategy designLisa J White
Centre for Clinical Vaccinology and Tropical Medicine, Nuffield Department of Clinical Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK
Malar J 8:212. 2009..However, in many malaria countries reliable data are not available and policy must be formed based on information like an estimate of the average parasite prevalence...